Enzychem in the News – Page 2 – Global New Drug Development Company |

News

August 13, 2020

FDA agrees to review Enzychem’s IND for COVID-19 trial

Explore further

Enzychem Lifesciences’ COVID-19 drug proceeds to phase 2 trial

Explore further

S. Korean bio firm wins FDA approval for clinical trials of coronavirus treatment

Explore further

Tests of COVID-19 treatments in Korea gain speed

Explore further

Enzychem files FDA Phase 2 study app to fight pneumonia due to COVID-19 – NJBIZ

Explore further

Enzychem submits IND for trial of COVID-19 treatment candidate

Explore further